Should Marijuana Be Reclassified as a Schedule II or III Drug?

Read pro and con arguments for moving marijuana out of Schedule I from experts such as the President and CEO of Mission Health Dr. Ronald Paulus (pro), Harvard Medical School professor Dr. Bertha Madras (con), the American College of Physicians (pro) and the US Food and Drug Administration (con).